For years, owning power meant betting on a slow, steady rise in demand as the economy grew. That story has suddenly changed. The machines b...

Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...

At the One of a Kind Awards - for early stage startups, presented by The Economic Times and Cashfree Payments, the Bootstrapped Champion Aw...

ICICI Bank has taken a significant step by doubling its overseas borrowing limit to five billion dollars. This strategic decision enhances ...

Shares of Kronox Lab Sciences surged after Indo Borax and Zenrock Chemicals announced plans to acquire a 64.26% stake in the company and la...

India Private Equity Investment 2026: Geopolitical risks now shape private equity deal considerations in India. Investors increasingly focu...

Private credit investments were broadly similar to the second half of 2025 levels of $3.4 billion, with refinancing, holding-company fundin...

Credent Connect N Care shares made a blockbuster debut on the NSE SME platform, listing at a 90% premium over the IPO price. The Rs 93.90-c...

Here’s one thing to watch for in the next few weeks: How does the street treat disappointments in the mid-cap segment? If the reaction is l...

Pharmaceuticals giant Cipla announced its merger with Inzpera Healthsciences Limited on Wednesday. This consolidation aims for more efficie...

Manipal Health Enterprises will acquire Kinder Women's Hospital in Bengaluru for Rs 130 crore. This business transfer agreement involves ac...

For the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...

For the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...

Aurobindo Pharma's US facility received a Voluntary Action Indicated classification. The US FDA closed its inspection of the Raleigh manufa...

Prime Minister Modi urged Indian pharmaceutical companies to reach global top five. The Indian pharma industry ranks third globally by volu...

In July, fund managers recalibrated their blue-chip stock portfolios, focusing on select sectors like IT, automotive, and pharmaceuticals f...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...